methylphenidate has been researched along with Atherosclerotic Parkinsonism in 3 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The causes of nigrostriatal neuron degeneration in Parkinson's disease (PD) are not known, but it has been suggested that exogenous or endogenous factors or neurotoxins may play a role." | 1.33 | An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate. ( Delville, Y; Fleming, SM; Schallert, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cucarián, JD | 1 |
| Berrío, JP | 1 |
| Rodrigues, C | 1 |
| Zancan, M | 1 |
| Wink, MR | 1 |
| de Oliveira, A | 1 |
| Cepeda, MS | 1 |
| Kern, DM | 1 |
| Seabrook, GR | 1 |
| Lovestone, S | 1 |
| Fleming, SM | 1 |
| Delville, Y | 1 |
| Schallert, T | 1 |
1 trial available for methylphenidate and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson's Drug Discovery.
Topics: Adrenergic beta-Antagonists; Adult; Antiparkinson Agents; Cohort Studies; Databases, Factual; Drug D | 2019 |
2 other studies available for methylphenidate and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease.
Topics: Animals; Dopaminergic Neurons; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem | 2019 |
An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Carbidopa; Cell Count; Differential Threshold; Dise | 2005 |